On Appeal, Scientists Dispute Inventorship Of Cancer Treatment Patents

Mealey's (March 30, 2020, 1:41 PM EDT) -- WASHINGTON, D.C. — In a March 25 appellee brief, the two named inventors of a patented treatment for castration resistant prostate cancer defend the rejection by a California federal judge of...
To view the full article, register now.